Scientists have created a fluorescent probe that can tag and illuminate single specimens of the bacteria that cause tuberculosis (TB), one of the world’s most problematic infectious diseases. The probe, along with a microfluidic chip that counts TB bacteria, could find applications in fields ranging from diagnosis of TB to assessing the effectiveness of novel therapies.
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb), is a highly contagious disease that infects the lungs and causes chronic coughs, fever, and weight loss. The disease is a massive burden on health systems worldwide, costing the world over $21 billion a year and being responsible for approximately two million deaths annually.
Efforts to rein in the malady have been hindered by the HIV epidemic, the spread of antibiotic resistance and the fact that the most common diagnostic techniques for TB are decades old. The bacteria can develop antibiotic resistance in part due to the presence of an enzyme named BlaC that breaks down the structure of many common antibiotics.
A team led by Yunfeng Cheng exploited this apparent strength by designing a molecule that is activated by BlaC and attaches to another enzyme named DprE1. The probe, named CDG-DNB3, produces a bright green color within one hour after activation by BlaC, allowing for rapid labeling of both single and multiple Mtb bacteria.
The authors tested the probe in a weakened variant of TB named BCG and found the probe could distinguish between live bacteria and dead bacteria, as well as between BCG and 43 related nontuberculosis mycobacterial species.
Chang et al. also created a chip using microfluidics technology that accurately counted bacteria within BCG samples labeled with CDG-DNB3 as they passed through a detection window.
IMAGE SOURCE: Creative Commons
The Scientific Inquirer needs your support. Please visit our Patreon page and discover ways that you can make a difference. http://bit.ly/2jjiagi